摘要
1文献来源
Attar EC, Johnson JL, Amrein PC, et al. Bortezomib added to Daunorubicin and Cytarabine during induction therapy and to intermediate-dose Cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502 [J]. J Clin Oncol, 2013,31(7) :923-929.
出处
《循证医学》
CSCD
2013年第5期268-270,273,共4页
The Journal of Evidence-Based Medicine
关键词
初治老年急性髓性白血病
硼替佐米
诱导治疗
巩固
previously untreated elderly adults acute myeloidleukemia
Bortezomib
induction therapy
consolidation